PROSTALUMIN DIN 02571757
Health Canada record
| Active ingredient(s) | (18F)PSMA-1007 3.7 GBQ |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | SCHEDULE C |
| Class | Radiopharmaceutical |
| ATC | V09IX17 PSMA-1007 (18F) |
| Original market date | |
| Current status date | 24-Sep-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Centre for Probe Development and Commercialization — licence 101848, not currently licensed, last inspection rating C (2022-05-30).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 38346 | 2026-09-24 | New Drug Submission (NDS) |